Drug-Induced Liver Injury - Types and Phenotypes.

Drug-Induced Liver Injury The liver has a range of responses to drug-induced injury, with a number of phenotypes. In addition, idiosyncratic reactions may occur as a consequence of both direct drug...

[1]  R. Fontana,et al.  Liver injury from nonsteroidal anti‐inflammatory drugs in the United States , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[2]  Paul B Watkins,et al.  Idiosyncratic Liver Injury: Challenges and Approaches , 2005, Toxicologic pathology.

[3]  R. Peters,et al.  Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases. , 1967, American journal of surgery.

[4]  Renwei Wang,et al.  The Safety of Green Tea Extract Supplementation in Postmenopausal Women at Risk for Breast Cancer: Results of the Minnesota Green Tea Trial , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  Rajvir Singh,et al.  Drug‐induced liver injury associated with stevens‐Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases , 2016, Hepatology.

[6]  D. Kleiner,et al.  Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma , 2012, Digestive Diseases and Sciences.

[7]  P. Meier,et al.  Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. , 2010, Seminars in liver disease.

[8]  T. A. Dalton,et al.  Hepatotoxicity associated with sustained-release niacin. , 1992, The American journal of medicine.

[9]  William M. Lee,et al.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. , 2015, Gastroenterology.

[10]  E. Björnsson,et al.  Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports , 2016, Hepatology.

[11]  Jiezhun Gu,et al.  Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network , 2014, Hepatology.

[12]  P. Hillon,et al.  Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.

[13]  P. Vanhems,et al.  The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. , 2011, Journal of hepatology.

[14]  H. Barnhart,et al.  Identification and Characterization of Fenofibrate-Induced Liver Injury , 2017, Digestive Diseases and Sciences.

[15]  D. Jevtović,et al.  The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients. , 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Luis Rodrigo,et al.  Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. , 2005, Gastroenterology.

[17]  R. Temple,et al.  Hy's law: predicting serious hepatotoxicity , 2006, Pharmacoepidemiology and drug safety.

[18]  J. Talwalkar,et al.  Drug‐induced autoimmune hepatitis: Clinical characteristics and prognosis , 2010, Hepatology.

[19]  Jiezhun Gu,et al.  Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity , 2013, Digestive Diseases and Sciences.

[20]  R. Fanin,et al.  Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT , 2017, Bone Marrow Transplantation.

[21]  William M. Lee,et al.  Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations , 2013, Hepatology.

[22]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[23]  G. Galatola,et al.  An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient. , 2009, American journal of clinical oncology.

[24]  G. McDonald.  Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On , 2010, Hepatology.

[25]  Jiezhun Gu,et al.  The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. , 2018, Journal of hepatology.

[26]  Jiezhun Gu,et al.  Amoxicillin–Clavulanate-Induced Liver Injury , 2016, Digestive Diseases and Sciences.

[27]  H. Devarbhavi,et al.  Drug‐Induced liver injury with hypersensitivity features has a better outcome: A single‐center experience of 39 children and adolescents , 2011, Hepatology.

[28]  F. Sacks,et al.  Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide. , 2014, JAMA internal medicine.

[29]  K. Stefánsson,et al.  A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. , 2019, Gastroenterology.

[30]  N. Bottini,et al.  PTPN22: the archetypal non-HLA autoimmunity gene , 2014, Nature Reviews Rheumatology.

[31]  A. Bergquist,et al.  Acute liver failure in Sweden: etiology and outcome , 2007, Journal of internal medicine.

[32]  William M. Lee,et al.  Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide , 2013, Digestive Diseases and Sciences.

[33]  C. Stephens,et al.  Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids , 2015, Alimentary pharmacology & therapeutics.

[34]  Jiezhun Gu,et al.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements , 2017, Hepatology.

[35]  S. Knowles,et al.  Anticonvulsant hypersensitivity syndrome: an update , 2012, Expert opinion on drug safety.

[36]  H. Conjeevaram,et al.  Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.

[37]  M. Mirabella,et al.  Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients , 2018, Brain and behavior.

[38]  R. D'Agostino,et al.  Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. , 2016, Blood.

[39]  R. Fontana,et al.  Causality assessment in drug‐induced liver injury using a structured expert opinion process: Comparison to the Roussel‐Uclaf causality assessment method , 2010, Hepatology.

[40]  M. Daly,et al.  HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin , 2009, Nature Genetics.

[41]  M. Pirmohamed,et al.  Characterization of amoxicillin‐ and clavulanic acid‐specific T cells in patients with amoxicillin‐clavulanate–induced liver injury , 2015, Hepatology.

[42]  M. Madariaga,et al.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[43]  Chandan Saha,et al.  Relationship between daily dose of oral medications and idiosyncratic drug‐induced liver injury: Search for signals , 2008, Hepatology.

[44]  S. Olafsson,et al.  Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , 2013, Gastroenterology.

[45]  G. McDonald,et al.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). , 2002, Seminars in liver disease.

[46]  R. Fontana,et al.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  Arie Regev,et al.  Drug-Induced Liver Injury and Drug Development: Industry Perspective , 2014, Seminars in Liver Disease.

[48]  A. Lok,et al.  Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg? , 2015, Hepatology.

[49]  M. Daly,et al.  Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. , 2011, Gastroenterology.

[50]  S. Kumra,et al.  Case study: risperidone-induced hepatotoxicity in pediatric patients. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[51]  W. Hwu,et al.  Reye's syndrome developing in an infant on treatment of Kawasaki syndrome , 2005, Journal of paediatrics and child health.

[52]  Michael Merz,et al.  Drug-induced liver injury: recent advances in diagnosis and risk assessment , 2017, Gut.

[53]  Jiezhun Gu,et al.  Idiosyncratic Drug Induced Liver Injury in African–Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians , 2017, The American Journal of Gastroenterology.

[54]  N. Chalasani,et al.  Features of Autoimmune Hepatitis in Patients With Drug‐induced Liver Injury , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[55]  J. Carcillo,et al.  Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. , 2011, The Pediatric infectious disease journal.

[56]  Elba Llop Herrera,et al.  Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease. , 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[57]  Jiezhun Gu,et al.  Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes , 2017, Journal of clinical gastroenterology.

[58]  P. Kamath,et al.  Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management , 2017, American journal of clinical oncology.

[59]  Jiezhun Gu,et al.  Clinical and histologic features of azithromycin-induced liver injury. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[60]  H. Bonkovsky.  Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). , 2006, Annals of internal medicine.

[61]  R. Fontana,et al.  Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study , 2016, Drug Safety.

[62]  A. White,et al.  Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[63]  H. Zimmerman,et al.  Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .

[64]  William M. Lee,et al.  Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study , 2005, Hepatology.

[65]  H. Barnhart,et al.  Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network , 2014, Hepatology.

[66]  N. Chalasani,et al.  Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States? , 2007, The American Journal of Gastroenterology.

[67]  Acute hepatitis after parenteral amiodarone administration. , 1989, British heart journal.

[68]  M. Avigan.  Drug Development : A Regulatory Perspective , 2014 .

[69]  H. Conjeevaram,et al.  Clinical and histopathologic features of fluoroquinolone-induced liver injury. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.